ARCHIVES

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Pharmacia Letter Announces Suspension Of Two Trials.

May 11, 2001

Congress Hasn’t Completed Action Yet On Major Health Bills; Reauthorization Fight In 1988-89

July 17, 1987

Harold Varmus Addresses the NCI Board of Scientific Advisors

March 8, 2013

NCI-Approved Clinical Trials

July 28, 2006

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

October 26, 1984

NCI Announces New Summer Training Awards

November 12, 1982